‘Immunomers’—novel 3′–3′‐linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents

By Yu Dong   Kandimalla Ekambar R.   Bhagat Lakshmi   Tang Jin‐Yan   Cong Yanping   Tang Jimmy   Agrawal Sudhir  

Nucleic Acids Research, Vol. 30, Iss. 20, 2002-10 ,pp. : 4460-4469

Oxford University Press

Access to resources Recommend Favorite

Fighting infection using immunomodulatory agents

By Masihi K Noel  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 641-653

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide-derived immunomodulatory drugs as therapeutic agents

By Galustian Christine   Labarthe Marie-Christine   Bartlett J Blake   Dalgleish Angus G  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 12, 2004-12 ,pp. : 1963-1970

Informa Healthcare

Access to resources Recommend Favorite

Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives

By Kumar Vivek   Madaan Alka   Sanna Vinod K.   Vishnoi Manupriya   Joshi Narendra   Singh Anu T.   Jaggi Manu   Sharma Pramod K.   Irchhaiya Raghuveer   Burman Anand C.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 5, 2009-10 ,pp. : 1169-1178

Informa Healthcare

Access to resources Recommend Favorite

Nanobodies as novel agents for cancer therapy

By Revets Hilde   De Baetselier Patrick   Muyldermans Serge  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 1, 2005-01 ,pp. : 111-124

Informa Healthcare

Access to resources Recommend Favorite